Titan Biotech Limited (BOM:524717)
437.15
+2.90 (0.67%)
At close: Sep 11, 2026
Titan Biotech Revenue
Titan Biotech had revenue of 591.67M INR in the quarter ending June 30, 2026, with 27.25% growth. This brings the company's revenue in the last twelve months to 2.19B, up 36.93% year-over-year. In the fiscal year ending March 31, 2026, Titan Biotech had annual revenue of 2.06B with 31.79% growth.
Revenue (ttm)
2.19B
Revenue Growth
+36.93%
P/S Ratio
8.25
Revenue / Employee
4.15M
Employees
467
Market Cap
18.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.06B | 497.40M | 31.79% |
| Mar 31, 2025 | 1.56B | -76.21M | -4.65% |
| Mar 31, 2024 | 1.64B | 200.73M | 13.94% |
| Mar 31, 2023 | 1.44B | 204.50M | 16.55% |
| Mar 31, 2022 | 1.24B | -186.92M | -13.14% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Renaissance Global | 30.63B |
| Goodyear India | 25.94B |
| TTK Healthcare | 8.88B |
| Modison | 8.47B |
| DISA India | 4.25B |
| Menon Bearings | 3.19B |
| Wendt (India) | 2.55B |
| Indo Borax & Chemicals | 2.15B |